Oct 2026· JCO Oncology Practice· pp.
OP2600472
· 0 citations· 52 references
Medicine
TL;DR
This qualitative review emphasizes IBC's clinical presentation, evolving diagnostic criteria, and current clinical management, including the standard trimodality approach for stage III management.
Abstract
Inflammatory breast cancer (IBC) is considered the most aggressive form of breast cancer and carries a poor prognosis, even with modern advancements in breast cancer care overall. It is rare, often misdiagnosed, and an understudied disease entity. This qualitative review emphasizes IBC's clinical presentation, evolving diagnostic criteria, and current clinical management, including the standard trimodality approach for stage III management. IBC-specific clinical trials are lacking, but we highlight current and upcoming interventional trials with dedicated IBC populations, demonstrating the future directions of this field, transforming management and improving patient outcomes.
Breast cancer is the most common and deadly type of cancer that affects women worldwide. A good anamnesis, allied with a highly accurate diagnosis and a correct interpretation of the data acquired relies the best chance for the patient to receive the best treatment and, in this direction, improve the chance of cure and...
M. de Souza Albernaz, Fagner Santos Do Carmo, Edward Helal-Neto et al.· European journal of oncology· 0 citations
Oral cavity carcinoma management always requires the involvement of a multidisciplinary team. Surgery is the mainstay of treatment, although other therapeutic modalities such as chemotherapy and radiotherapy are often needed in a multimodal treatment approach. Accurate staging is of great importance to better define th...
O. Iocca, Ghayoour Mir, Imraan Jan et al.· Oral and Maxillofacial Surge...· 0 citations
Male breast cancer (MBC) is a rare malignancy accounting for less than 1% of all breast cancers and less than 1% of cancers in men. Compared with female breast cancer, MBC is characterized by a predominance of hormone receptor-positive luminal tumors, whereas evidence guiding individualized management remains largely e...
Li-Min Fan, Lin Tan, Wu Tang· Frontiers in Oncology· 0 citations
Simple Summary Triple-negative breast cancer (TNBC) is an aggressive and clinically complex form of breast cancer that presents substantial challenges in diagnosis, treatment, and long-term management. This review discusses the major clinical challenges associated with TNBC, together with the currently available treatm...
Breast cancer (BC) is the most frequently diagnosed cancer among women and the leading cause of cancer deaths in females globally. In the United States, more than 300,000 new cases of invasive BC are diagnosed annually, and more than 40,000 patients die of metastatic BC. Herein, we discuss the current and evolving mana...
Kathryn J. Ruddy, D. Idossa, Dalliah M. Black et al.· Mayo Clinic proceedings· 0 citations
Background: Breast cancer is the most common malignant neoplasm among women; the World Health Organization notes that incidence rates are 88% higher in developed countries than in developing ones. Ductal carcinoma is the most common type of breast cancer, accounting for 70% to 80% of all invasive cases, while lobular c...
A. J. Reyes Pintor, C. A. Montaño-Salvador, B. N. Lozano-Garcia· International Journal of Adv...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.